Skip to main content
. 2016 Mar 10;2016(3):MR000043. doi: 10.1002/14651858.MR000043.pub2

Näslund 1999.

Methods RCT comparing inogatran versus heparin in unstable coronary disease.
Data 1209 patients were randomised (904/305, respectively in each treatment group).
Comparisons Onsite assessment (local investigator blinded) versus assessment by an AC (blinding status not reported).
Outcomes The outcome selected was death, myocardial infarction (reinfarction), refractory angina or recurrent angina.The study's primary outcome was a composite of these events at 7 days.
Notes  
Risk of bias
Item Authors' judgement Description
Method for selecting cases to adjudicate? No All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment.